Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
ACS Pharmacology & Translational Science
|
February 19, 2026
Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures"
Antonia C Darragh, Andrew M Hanna, Justin Lipner, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Impact of Methylated Cyclodextrin KLEPTOSE<sup>®</sup> CRYSMEB on Inflammatory Responses in Human In Vitro Models
Damien Truffin, Flora Marchand, Mathias Chatelais, et al.
Analytical and Bioanalytical Chemistry
|
November 7, 2007
A cell-based screening method for specifically detecting kinase activity
Mikiya Suda, Tsuyoshi Ishii, Hiroshi Sootome, et al.
ACS Pharmacology & Translational Science
|
April 17, 2025
Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures
Antonia C Darragh, Andrew M Hanna, Justin H Lipner, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors
Tsuyoshi Ish, Hiroshi Sootome, Alastair J King, et al.
ACS Pharmacology & Translational Science
|
May 14, 2026
Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures"
Antonia C Darragh, Andrew M Hanna, Justin H Lipner, et al.
Gastroenterology
|
April 29, 2008
The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis
Kazuhiro Noma, Keiran S M Smalley, Mercedes Lioni, et al.
Cancer Research
|
July 18, 2008
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S M Smalley, Rooha Contractor, Thiennga K Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2006
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues
Lata T Gooljarsingh, Christine Fernandes, Kang Yan, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas
Keiran S M Smalley, Mercedes Lioni, Maurizia Dalla Palma, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
ACS Pharmacology & Translational Science
|
February 19, 2026
Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures"
Antonia C Darragh, Andrew M Hanna, Justin Lipner, et al.
International Journal of Molecular Sciences
|
September 14, 2024
Impact of Methylated Cyclodextrin KLEPTOSE<sup>®</sup> CRYSMEB on Inflammatory Responses in Human In Vitro Models
Damien Truffin, Flora Marchand, Mathias Chatelais, et al.
Analytical and Bioanalytical Chemistry
|
November 7, 2007
A cell-based screening method for specifically detecting kinase activity
Mikiya Suda, Tsuyoshi Ishii, Hiroshi Sootome, et al.
ACS Pharmacology & Translational Science
|
April 17, 2025
Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures
Antonia C Darragh, Andrew M Hanna, Justin H Lipner, et al.
Journal of Biomolecular Screening
|
May 23, 2007
A robust, target-driven, cell-based assay for checkpoint kinase 1 inhibitors
Tsuyoshi Ish, Hiroshi Sootome, Alastair J King, et al.
ACS Pharmacology & Translational Science
|
May 14, 2026
Correction to "Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures"
Antonia C Darragh, Andrew M Hanna, Justin H Lipner, et al.
Gastroenterology
|
April 29, 2008
The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis
Kazuhiro Noma, Keiran S M Smalley, Mercedes Lioni, et al.
Cancer Research
|
July 18, 2008
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S M Smalley, Rooha Contractor, Thiennga K Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 11, 2006
A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues
Lata T Gooljarsingh, Christine Fernandes, Kang Yan, et al.
Molecular Cancer Therapeutics
|
September 16, 2008
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas
Keiran S M Smalley, Mercedes Lioni, Maurizia Dalla Palma, et al.
Page
of 2